Joseph M. Curry, MD

Articles by Joseph M. Curry, MD

Neoadjuvant Cemiplimab in BCC of the Head and Neck | Image Credit: © Galina - stock.adobe.com

Dr Kenny on Phase 2 Data With Neoadjuvant Cemiplimab in BCC of the Head and Neck

ByHannah Kenny, MD,Joseph M. Curry, MD

July 16th 2026

Hannah Kenny, MD, and Joseph M. Curry, MD, discuss findings from a phase 2 study of cemiplimab in locally advanced BCC of the head and neck.

Latest Updated Articles

Trending on OncLive

Dr Mesa on the FDA Approval of Ropeginterferon Alfa-2b for Essential Thrombocythemia

FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia

Savolitinib Plus Osimertinib Improves First-Line PFS in MET-Overexpressing EGFR-Mutated NSCLC

FDA Receives sNDA for Selinexor Plus Ruxolitinib in JAK Inhibitor–Naive Myelofibrosis

Zanidatamab Plus Chemotherapy Improves OS at Second Interim Analysis of HERIZON-GEA-01 in First-Line HER2+ GEA